Adare Pharma Solutions has strengthened its executive leadership team with two key hires. Robert Muschert has joined Adare as Chief Commercial Officer, and Dr. Vipan Dhall has joined as Chief Scientific Officer. These key additions aim to further advance Adare’s position as a technology driven CDMO solving unique formulation challenges in partnership with pharmaceutical companies.

Bob will lead commercial strategy and business development efforts for the company with responsibility for all business development, marketing, and commercial operations activities. Bob and the APS commercial team will continue to bolster Adare’s services in the field of oral dosage formulations, and to expand the brand with a diverse range of technology offerings in new markets.

Bob brings nearly 30 years of pharmaceutical industry experience to Adare. His career has spanned business development and sales, supply chain and manufacturing operations, strategic procurement, and technical services in global pharmaceutical and services organizations. Most recently, Bob was Head of Sales, US Global Account Management Lonza, where he oversaw account management and business development for the company’s east coast partners and new business relationships.  Prior, Bob held various roles at Hovione, Pfizer, and Merck.

Vipan will work to bolster Adare’s technologies, capabilities, and services. Vipan is charged with leading oral dosage forms and efforts to enhance additional competencies and technologies. He is responsible for Adare’s pharmaceutical development, technical services and business support, and regulatory affairs teams.

Vipan has more than 25 years of pharmaceutical development experience in traditional pharma as well as the CDMO space. He has held scientific leadership across North America, Europe, and Asia in the pharmaceutical development, analytical development, clinical and drug-discovery spaces. Prior to joining Adare, Vipan was Vice President of Life Sciences, North America at SGS. Previously, he was VP and Global Head of Formulations and Product Development R&D at Piramal Pharma Solutions, a global CDMO.  

“The pharmaceutical industry is undergoing a growing trend toward outsourcing development and commercialization of products,” said Vivek Sharma, Adare Pharma Solutions Chief Executive Officer. “We have refined our strategy to better capitalize on these trends, and the addition of Bob and Vipan to Adare’s leadership will help us accelerate that strategy. These experienced executives bring the expertise, relationships, and technical skills to help Adare achieve our vision to be a differentiated, customer-centric, technology-driven CDMO.”